Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 390 participants.
Also called NCT02829151
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 390 participants
- Sponsor
- Registry
-
NCT02829151
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02829151. Randomized; no masking; primary purpose treatment. Start 2017-02-21 (actual); primary completion 2021-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)
- Condition
- Critical Limb Ischemia
- Intervention (Drug)
- Triple antiplatelet therapy (aspirin (100 mg), clopidogrel (75 mg), and cilostazol (200 mg) )
- Intervention (Drug)
- Dual antiplatelet therapy (aspirin (100 mg) and clopidogrel (75 mg)) using aspirin and clopidogrel
- Intervention (Drug)
- Dual antiplatelet therapy (aspirin (100 mg) and cilostazol (200 mg)) using aspirin and cilostazol
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct02829151- Content hash
f1f51786463d84947e135ae450e07498d5f1996edad69be22e36fdd864b1cefb